Pain Management
In Best Practice
dr. Hardhi Pranata, Sp.S, MARS
PDHMI (Perkumpulan Disiplin Herbal Medik Indonesia)
21 Maret 2021
-PAIN
unpleasant sensory & emotionalPsychological & certain autonomic (involuntary) responses behavioural reactions provoked by tissue damage.
A COMPLEX CONSTELLATON:
Pain & Covid-19
•Chronic pain management during the coronavirus
disease 2019 (COVID-19) pandemic is a challenging
process, especially with growing evidence that
COVID-19 infection is associated with headache,
myalgia, referred pain, and widespread
hyperalgesia
Tallawy et al., 2020
• Biochemical Theories pain-producing, pain- mediating and
pain chemoreceptors are located in the brain Endogenous
opiates – inhibits pain by blocking substance P. in
Periacquedactal gray area
• Chemical pain mediators and inhibitors:
Bradykinin, Histamine, prostaglandin
Theory of Pain:
•Glutamate - Central •Substance P - Central •Brandykinin - Peripheral •Prostaglandins – Peripheral •Aspartate
Pain
Initiators
•Serotonin •Endorphins •EnkephalinsPain
Inhibitors
NEUROTRANSMITTERS
•Dynorphin •GABA •GlycinePAIN CLASSIFICATION
1. Acute
2. Chronic :
a) Non malignant
b) Malignant
Types of Pain Nociceptive Somatic Visceral Neuropathic Peripheral Central MixedTYPES OF PAIN
Modulation
Mediators of Nociceptive Pain
• Nociceptors are specifically designed receptors to detect stimuli that may cause harm to the body, which may be mechanical, chemical or thermal in nature. • Aᵟ fibres mediate sharp localised pain
• C fibres mediate dull and burning pain
3. Mixed Pain
2. Neuropathic:
Nociceptive pain may be somatic or visceral in origin.
-Visceral pain: Originates in nociceptors located in the hollow organs and smooth muscles; it is often referred. E.g. Dysmenorrhea, gastritis, appendicitis or acute pancreatitis
-Somatic pain: Originates from musculoskeletal, joint or cutaneous nociceptors and is often well localized. E.g. Gout, osteoarthritis, skin incision and trauma-induced pain.
3. Mixed Pain
2. Neuropathic:
1. Nociceptive:
▪ Caused by pressure on &/or destruction of
peripheral, autonomic or central nervous system structures.
▪ May arise from a lesion or trauma, infection, compression or tumour invasion.
▪ Described as burning, shooting, tingling.
▪ Does not respond well to standard analgesics.
3. Mixed Pain
2. Neuropathic:
Peripheral Neuropathic Pain: Central Neuropathic Pain:
3. Mixed Pain
2. Neuropathic:
1. Nociceptive:
• Central post stroke pain • Neuropathic associated with
spinal cord injury
• Traumatic brachial plexus injury • Diabetes Mellitus
• Carpel tunnel syndrome • Post herpetic neuralgia
Recognizing Neuropathic Pain
Be alert for common verbal descriptors of neuropathic pain:
Burning Tingling Shooting Electric shock-like Numbness
3. Mixed Pain
2. Neuropathic:
INSTRUMENTS FOR ASSESSING
PAIN PERCEPTION
• VISUAL ANALOGUE SCALES(VAS)
Goals of Pain Management
Therapy
1) Decreased pain
2) Decreased healthcare utilization
o
Decreased “shopping” for care
o
Decreased emergency room visits
3) Improved functional status
o
Increased ability to perform activities of daily living
o
Return to employment
Pregabalin GENERAL APPROACH TO PAIN THERAPY
Management
• Non-Pharamcological treatment
• Pharmacological treatment:
• Analgesics
• Adjuvants
• Others
PAIN THERAPY
Non-pharmacological
Intervention Phar macologicalIntervention
• Superficial Heat • Exercise • Cryotherapy • Acupuncture • Acupressure • etc • Non opioid • Weak opioid • Strong opioid
PHARMACOLOGICAL INTERVENTION
WHO 3-step Analgesic ladder
PharmacologicalIntervention
Analgesic ladder in action:
◼ Step 1: non-opioid analgesics (Paracetamol
and Aspirins, NSAIDS)
◼ Step 2: mild opioid is added (not
substituted) to step 1
◼ Step 3: Opioid for moderate to severe pain
is used and titrated to effect
• Used in full doses for the most part.
• All have a ceiling effect to their analgesia (a maximum dose past which no further analgesia can be expected).
• COX-2 inhibitors may be associated with fewer side-effects
a) Analgesics (Non-opioids)
Pharmacological Intervention
• Use
cytoprotection
with NSAIDs only in
patients who have symptoms suggestive of
GI distress or who are at high risk of ulcer
formation.
• For cytoprotection use sulcrafate or
misoprostol.
Pharmacological Intervention
b) Analgesics (
Weak
Opioids)
• Codeine & codeine combination products
USEFUL
• Morphine , hydromorphone, fentanyl,
oxycodone , methadone.
c) Analgesics (
Strong
Opioids)
Adjuvant analgesics (coanalgesics)
▪ Are medications that when added to primary
analgesics, further improve pain control.
▪ may themselves also be primary analgesics (e.g.
tricyclic antidepressant medications for postherpetic
neuralgia).
▪ They can be added into the pain management plan at
any step in the WHO ladder.
▪ Cyclic Antidepressants: o Amitriptyline
▪ Anticonvulsants:
o Carbamazepine - Valproic acid - Gabapentin - Pregabalin ▪ Local Anesthetics:
o Lidocaine
Other modalities
▪ Nerve blocks, epidural blocks and ablative
neurosurgical procedures may be effective in pain
management.
OMAI
OHT
Terstandar kandungannya Uji pra-klinik keamanan & khasiatnya
eg:
Herbapain Bodrex Herbal Kiranti pegel linu Rheumakur
Neo Rheumacyl Herbal Pain Neosendi
Dismeno
Obat Bahan Alam Indonesia Fitofarmaka
Uji praklinik & uji klinik
eg:
• Inlacin (Kayu Manis) untuk diabetes mellitus • Redacid untuk gastritis
• Stimuno (meniran) untuk meningkatkan imunitas
• Disolf untuk stroke
Herbal Anti-Nyeri/ Inflamasi
Cengkeh
(
Syzygium aromaticum
)
Kandungan utama: Eugenol. Kaempferol, Quercetin
Uji PraKlinik: Dapat mengurangi radang pada tikus dengan cara menghambat induksi InterLeukin-8 (IL8) pada makrofag
Herbal Anti-Nyeri/ Inflamasi
Jahe
(
Zingiber officinale
)
Kandungan utama: Cineol, Gingerol, Zingiber
Uji Laboratoris: Mengahambat sintesa prostaglandin dan leukotriene Indikasi: AntiNyeri, Anti-radang sendi
Herbal Anti-Nyeri/ Inflamasi
Cabe
(
Capsicum annum L.
)
Kandungan utama: Capcaisin, Zea Xanthine, Lutein
Uji PraKlinik: Capcaisin menyebabkan rasa nyeri terbakar pada daerah kulit melalui mekanisme pelepasan neuro-peptide (substansi P) sehingga menghilangkan nyeri nociceptive & neuropatik
Herbal Anti-Nyeri/ Inflamasi
Serai
(
Cymbopogon citratus)
Kandungan utama: Cytronelal, Geraniol
Uji PraKlinik: Ekstrak rebusan serai menginhibisi nyeri Indikasi: Sebagai Minuman untuk mengurangi nyeri
Herbal Anti-Nyeri/ Inflamasi
Temulawak
(
Curcuma xanthorrhiza)
Kandungan utama: Curcumin, Xanthorizol, Turmeron Uji Klinik: (Nyoman Kertia, 1997) 22 pasien OA lutut Diberikan 15mg curcuminoid + 200mg atsiri temulawak - 2x sehari ---- selama 14 hari
Herbal Anti-Nyeri/ Inflamasi
Kunyit
(
Curcuma longa)
Kandungan utama: Curcumoid, Turmeron, Zingiberon Uji PraKlinik: Menghambat fase lipo-oksigenase dan siklo-oksigenase sehingga sintesa prostaglandin-2 menurun Indikasi: Anti-Nyeri, Anti-Radang sendi
Herbal Anti-Nyeri/ Inflamasi
Mahkota Dewa
(
Phaleria macrocarpa)
Kandungan utama: Alkaloid, Flavonoid, Lignan, Saponin Cara Kerja: Menghambat fase lipo-oksigenase dan siklo-oksigenase sehingga sintesa prostaglandin-2 menurun Indikasi: Nyeri kepala, nyeri otot
Penggunaan DLBS1442 DALAM
MenGURANGI Nyeri
Mekanisme Kerja DLBS1422
• Kandungan flavonoid, fenol, terpenoid, terbukti dapat mengurangi inflamasi dengan cara menekan pelepasan prostaglandin oleh jalur penghambatan COX-2
• Selain itu, aktivitas antioksidan dari Mahkota Dewa juga berperan dalam penghambatan nitric oxide (NO) yang berperan dalam proses inflamasi
Uji Praklinik Serbuk Ekstrak Kering Tumbuhan DLBS1442 (mahkota dewa)
sebagai Antinyeri
Soemardji AA, Safitri D, Rahmawati SF. Preclinical study of DLBS1442 as analgesic (Siegmund method). Institut Teknologi Bandung, Bandung 2016. Data on file.
Tujuan penelitian
untuk menguji aktivitas DLBS1422 dalam meredakan nyeri
Dosis penggunaan
200 mg atau 0.2 gram untuk orang dewasa (70 kg) setara dengan dosis 0,026 g/kgBB mencit
Obat pembanding
Natrium diklofenak dan Ibuprofen (dosis obat pembanding yang digunakan setara dengan dosis pemakaian pada manusia dewasa 70 kgBB)
42
Profil jumlah geliatan mencit setiap 10 menit selama waktu pengamatan
Kesimpulan:
Dari hasil analisis statistik, kelompok yang diberikan dosis rendah (0,026 g/kgBB) dan
dosis tengah (0,052g/kgBB) memiliki geliatan/writhing response (respons rasa sakit)
yang lebih rendah secara bermakna dibandingkan dengan kelompok kontrol
Soemardji AA, Safitri D, Rahmawati SF. Preclinical study of DLBS1442 as analgesic (Siegmund method). Institut Teknologi Bandung, Bandung 2016. Data on file.
Symptomatic treatment of
premenstrual syndrome and/or
primary dysmenorrhea with
DLBS1442, a bioactive extract of
Phaleria macrocarpa
45
Pain in the stomach Breast Pain Back Pain
Headache
Dari penelitian ini didapatkan bahwa efektivitas dari DLBS1442 (Predimenol) dapat meringankan simptom nyeri yang disebabkan oleh PMS dimana secara keseluruhan menunjukkan VAS score yang lebih rendah setelah diberikan DLBS1442
Tjandrawinata RR, et al. Symptomatic treatment of premenstrual syndrome and/or primary dysmenorrhea with DLBS1442, a bioactive extract of Phaleria macrocarpa. International Journal of General Medicine 2011:4 465– 476
DLBS1442
• Memiliki efek anti-inflamasi dengan cara menekan COX2-mRNA • Sehingga terjadi penurunan Prostaglandin-E2 (PGE2)
• Buah mahkota dewa juga menghambat xanthine oksidase dan lipo-oksigenase
• DLBS1442 berfungsi sebagai moderate anti-inflamasi
Hasil formulasi dari ekstraksi teknologi tinggi dari buah mahkota dewa (Phalia marcocarpa) pada uji laboratorium
RAMUAN IMUNOMODULATOR
Komposisi:
- Sambiloto, Meniran, Akar Manis, Jahe Emprit, Daun Jambu Mede
Kandungan: Lakton, kolmegin, andographolid
Khasiat: Anti nyeri, Anti radang, Anti virus, Anti bakteri SAMBILOTO (Andrographis paniculata)
Kandungan: Phylantin, Mirantin MENIRAN (Phyllanthus urinaria)
Kandungan: Gingerol, Shogaol, Zingiberol
Khasiat: Anti kembung, Anti mual, Anti radang, Anti bakteri
JAHE EMPRIT (Zingiber officinale var. amarumdengan)
Khasiat: Mengurangi sesak napas, mengurangi dahak, anti virus, anti nyeri
DAUN JAMBU MEDE (Anacardium occidentale)
RAMUAN IMUNOMODULATOR
Kandungan: Flavonoid, Glycyrrhizin, Licorice
Khasiat: Melancarkan pernapasan, mengurangi batuk,
anti nyeri lambung, anti bakteri